Comprehensive Analysis Identifies CLEC1B as a Potential Prognostic Biomarker in Hepatocellular Carcinoma

The expression of C-type lectin domain family 1 member B (CLEC1B) was explored using The Cancer Genome Atlas and Gene Expression Omnibus databases. RT-qPCR, western blot, and immunohistochemistry assays were employed to validate the downregulation of CLEC1B.